Cold sore treatment: RELEEV clinically proven to be fastest OTC cold sore relief product

Clinical trial shows the Merix Pharmaceutical product provides complete and fast acting treatment for cold sore symptoms in just 24 hours
(PR NewsChannel) / June 11, 2014 / CHICAGO 

The fast-acting cold sore treatment Releev can cure symptoms in as quickly as 24 hours.

The fast-acting cold sore treatment Releev can cure symptoms in as quickly as 24 hours.

The cold sore remedy product RELEEV is now clinically proven to be the only product to provide rapid healing of all symptoms in just 24 hours, bringing its users relief quicker than any other over-the-counter medication.

RELEEV is a non-toxic cold sore treatment comprised of a special botanical extract called Viracea, a licensed formula made specifically to treat herpes-caused cold sores. The fast-acting cold sore treatment was also clinically proven to heal outbreaks faster than any product known.

Merix Pharmaceuticals, the manufacturer of the FDA regulated cold sore remedy, strives to ease pain caused by infectious diseases through the use phytochemicals, chemical compounds that naturally occur in plants.

“We understand that consumers want to have their outbreaks treated as quickly and painlessly as possible,” said Meryl Squires, the founder of Merix Pharmaceuticals. “Our goal is to provide this fast relief using the safest and most natural compounds.”

Squires has been specializing in bio-medical research, phyto-pharmacognosy and application of phyto-pharmaceuticals since 1978 and founded Merix Pharmaceuticals in 1998.

Cold sores, also known commonly as fever blisters, are groups of small blisters on the lip and around the mouth and are caused by the herpes simplex virus (HSV).

The fast-acting cold sore treatment can be purchased in most major pharmacies in the United States including CVS, Rite Aid, Walgreens, Walmart, and is also available online at

For more information please visit

About Merix Pharmaceutical Corporation: Merix Pharmaceutical Corporation was established in 1998 and is a pioneering U.S corporation committed to easing the pain and suffering caused by infectious diseases. The corporation focuses on the utilization of phyto-pharmaceutical technology specializing in the area of antivirals. Merix’ primary mission is to develop and market phyto-chemical based medicines which provide potentially safer and more effective treatments.

Based on the licenses Merix has on the phyto-chemical based formulas Viracea and Viracea 2.4,the company has developed several formulations and will market them into the worldwide consumer health, OTC, and pharmaceuticals markets.

Tyler Ragghianti
The Publicity Agency
Phone: (813) 708-1220 x7780

Nathan Legg
The Publicity Agency
Phone: (813) 708-1220 x 7781

Direct link:

SOURCE:  Merix Pharmaceutical

This press release is distributed by PR NewsChannel. Your News. Everywhere.